Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

Science 312 (5777): 1162-1165

Copyright © 2006 by the American Association for the Advancement of Science

The New Era in Cancer Research

Harold Varmus

Abstract: For many years, discoveries about the genetic determinants of cancer appeared to be having only minor effects on efforts to control the disease in the clinic. Following advances made over the past decade, however, a description of cancer in molecular terms seems increasingly likely to improve the ways in which human cancers are detected, classified, monitored, and (especially) treated. Achieving the medical promise of this new era in cancer research will require a deeper understanding of the biology of cancer and imaginative application of new knowledge in the clinic, as well as political, social, and cultural changes.

Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

E-mail: varmus{at}mskcc.org


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
The mTOR pathway negatively controls ATM by up-regulating miRNAs.
C. Shen and P. J. Houghton (2013)
PNAS 110, 11869-11874
   Abstract »    Full Text »    PDF »
Targeted Nanoparticles That Deliver a Sustained, Specific Release of Paclitaxel to Irradiated Tumors.
R. J. Passarella, D. E. Spratt, A. E. van der Ende, J. G. Phillips, H. Wu, V. Sathiyakumar, L. Zhou, D. E. Hallahan, E. Harth, and R. Diaz (2010)
Cancer Res. 70, 4550-4559
   Abstract »    Full Text »    PDF »
Oncogenic Activating Mutations Are Associated with Local Copy Gain.
B. Modrek, L. Ge, A. Pandita, E. Lin, S. Mohan, P. Yue, S. Guerrero, W. M. Lin, T. Pham, Z. Modrusan, et al. (2009)
Mol. Cancer Res. 7, 1244-1252
   Abstract »    Full Text »    PDF »
EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts.
B. Lal, C. R. Goodwin, Y. Sang, C. A. Foss, K. Cornet, S. Muzamil, M. G. Pomper, J. Kim, and J. Laterra (2009)
Mol. Cancer Ther. 8, 1751-1760
   Abstract »    Full Text »    PDF »
Durable Long-Term Remission With Chemotherapy Alone for Stage II to IV Laryngeal Cancer.
F. C. Holsinger, M. S. Kies, E. M. Diaz Jr, A. M. Gillenwater, J. S. Lewin, L. E. Ginsberg, B. S. Glisson, A. S. Garden, N. Ark, H. Y. Lin, et al. (2009)
J. Clin. Oncol. 27, 1976-1982
   Abstract »    Full Text »    PDF »
Pro-apoptosis and Anti-proliferation Effects of a Recombinant Dominant-negative Survivin-T34A in Human Cancer Cells.
C. SHEN, W. LIU, A. K. BUCK, and S. N. RESKE (2009)
Anticancer Res 29, 1423-1428
   Abstract »    Full Text »    PDF »
Genome-Wide Promoter Analysis Uncovers Portions of the Cancer Methylome.
M. O. Hoque, M. S. Kim, K. L. Ostrow, J. Liu, G. B. A. Wisman, H. L. Park, M. L. Poeta, C. Jeronimo, R. Henrique, A. Lendvai, et al. (2008)
Cancer Res. 68, 2661-2670
   Abstract »    Full Text »    PDF »
An In vivo Model of Met-Driven Lymphoma as a Tool to Explore the Therapeutic Potential of Met Inhibitors.
P. Accornero, G. Lattanzio, T. Mangano, R. Chiarle, R. Taulli, F. Bersani, P. E. Forni, S. Miretti, C. Scuoppo, W. Dastru, et al. (2008)
Clin. Cancer Res. 14, 2220-2226
   Abstract »    Full Text »    PDF »
Coactivation of Receptor Tyrosine Kinases Affects the Response of Tumor Cells to Targeted Therapies.
J. M. Stommel, A. C. Kimmelman, H. Ying, R. Nabioullin, A. H. Ponugoti, R. Wiedemeyer, A. H. Stegh, J. E. Bradner, K. L. Ligon, C. Brennan, et al. (2007)
Science 318, 287-290
   Abstract »    Full Text »    PDF »
Histological and proteomic analysis of reversible H-RasV12G expression in transgenic mouse skin.
W.-J. Oh, V. Rishi, S. Pelech, and C. Vinson (2007)
Carcinogenesis 28, 2244-2252
   Abstract »    Full Text »    PDF »
In utero exposure to maternal diets containing soy protein isolate, but not genistein alone, protects young adult rat offspring from NMU-induced mammary tumorigenesis.
Y. Su, R. R. Eason, Y. Geng, S. Till, T. M. Badger, and R. C.M. Simmen (2007)
Carcinogenesis 28, 1046-1051
   Abstract »    Full Text »    PDF »
Human Bone Marrow Activates the Akt Pathway in Metastatic Prostate Cells through Transactivation of the {alpha}-Platelet-Derived Growth Factor Receptor.
N. G. Dolloff, M. R. Russell, N. Loizos, and A. Fatatis (2007)
Cancer Res. 67, 555-562
   Abstract »    Full Text »    PDF »
PTEN-Mediated Resistance to Epidermal Growth Factor Receptor Kinase Inhibitors.
I. K. Mellinghoff, T. F. Cloughesy, and P. S. Mischel (2007)
Clin. Cancer Res. 13, 378-381
   Abstract »    Full Text »    PDF »
The Consensus Coding Sequences of Human Breast and Colorectal Cancers.
T. Sjoblom, S. Jones, L. D. Wood, D. W. Parsons, J. Lin, T. D. Barber, D. Mandelker, R. J. Leary, J. Ptak, N. Silliman, et al. (2006)
Science 314, 268-274
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882